GCM
NSPR icon

Ghisallo Capital Management’s InspireMD NSPR Stock Holding History

Ghisallo Capital Management’s Portfolio NSPR Stock Details NSPR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-921,587
Closed -$2.22M – 240
2025
Q3 		$2.22M Buy
+921,587
New +$2.24M 0.07% 172

Other funds holding NSPR

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Ghisallo Capital Management's NSPR Position: Q4 2025 in Review

Ghisallo Capital Management sold out of InspireMD (NSPR) in Q4 2025, closing a stake of 921,587 shares — an estimated $2.22M sold.

Ghisallo Capital Management first reported a position in NSPR in Q3 2025 and held it in 1 quarter. The position peaked at $2.22M in Q3 2025. 45 funds tracked by Wall St. Rank hold NSPR as of Q4 2025.

  • Ghisallo Capital Management reported no remaining InspireMD position as of Q4 2025 after selling out during the quarter.
  • Ghisallo Capital Management sold 921,587 InspireMD shares in Q4 2025, an estimated $2.22M.
  • Ghisallo Capital Management first reported a position in InspireMD in Q3 2025 and held it in 1 quarter.
  • Ghisallo Capital Management's InspireMD position peaked at $2.22M in Q3 2025.
  • 45 funds tracked by Wall St. Rank held InspireMD as of Q4 2025.

Based on Ghisallo Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.